Ken Fisher's position in Thermo Fisher Scientific is currently worth $1.1 Billion. That's 0.46% of their equity portfolio (58th largest holding). The first Thermo Fisher Scientific trade was made in Q4 2015. Since then Ken Fisher bought shares 26 more times and sold shares on ten occasions. The investor's estimated purchase price is $1.11 Billion, resulting in a loss of 1.5%.
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Medical Refrigerators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's of...
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the...
Strength in Analytical Instrument and Laboratory Products and Services segments is likely to have driven Thermo Fisher's (TMO) second-quarter 2024 performance.
DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.